Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Cagrilintide C194H312N54O59S2 CID 171397054 PubChem Cagrilintide Research Peptide Information Peptpedia Stalled results on Tirzepatide? You need to add Cagrilintide to your GLP 1 stack! #fyp #glp1 #foryoupag #tirzepatide #glp1medication #xybzca #glp1community In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintidesemaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results Cagrilintide Combined with Semaglutide: A New Approach for Treatment of Obesity and Type 2 Diabetes ClinicSearch